Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study
Sign Up to like & getrecommendations! Published in 2022 at "Hepatology International"
DOI: 10.1007/s12072-022-10332-9
Abstract: Data on safety and immunogenicity of coronavirus disease 2019 (COVID-19) vaccination in patients with compensated (C-cirrhosis) and decompensated cirrhosis (D-cirrhosis) are limited. In this prospective multicenter study, adult participants with C-cirrhosis and D-cirrhosis were enrolled… read more here.
Keywords: prospective multicenter; safety immunogenicity; cirrhosis cirrhosis; multicenter study ... See more keywords